Literature DB >> 35040885

What Is Polycystic Ovary Syndrome?

Kristin Walter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35040885     DOI： 10.1001/jama.2021.19776

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.

Authors:  Jiaqi Zhang; Chuan Xing; Xiangyi Cheng; Bing He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

Review 2.  The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility.

Authors:  Yu-Qian Shi; Yi Wang; Xi-Ting Zhu; Rui-Yang Yin; Yi-Fu Ma; Han Han; Yan-Hua Han; Yue-Hui Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-07       Impact factor: 2.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.